Correlation Between KABE Group and Alligator Bioscience
Can any of the company-specific risk be diversified away by investing in both KABE Group and Alligator Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining KABE Group and Alligator Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between KABE Group AB and Alligator Bioscience AB, you can compare the effects of market volatilities on KABE Group and Alligator Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in KABE Group with a short position of Alligator Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of KABE Group and Alligator Bioscience.
Diversification Opportunities for KABE Group and Alligator Bioscience
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between KABE and Alligator is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding KABE Group AB and Alligator Bioscience AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alligator Bioscience and KABE Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on KABE Group AB are associated (or correlated) with Alligator Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alligator Bioscience has no effect on the direction of KABE Group i.e., KABE Group and Alligator Bioscience go up and down completely randomly.
Pair Corralation between KABE Group and Alligator Bioscience
Assuming the 90 days trading horizon KABE Group is expected to generate 2.59 times less return on investment than Alligator Bioscience. But when comparing it to its historical volatility, KABE Group AB is 9.15 times less risky than Alligator Bioscience. It trades about 0.23 of its potential returns per unit of risk. Alligator Bioscience AB is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 24.00 in Alligator Bioscience AB on October 8, 2024 and sell it today you would earn a total of 1.00 from holding Alligator Bioscience AB or generate 4.17% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
KABE Group AB vs. Alligator Bioscience AB
Performance |
Timeline |
KABE Group AB |
Alligator Bioscience |
KABE Group and Alligator Bioscience Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with KABE Group and Alligator Bioscience
The main advantage of trading using opposite KABE Group and Alligator Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if KABE Group position performs unexpectedly, Alligator Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alligator Bioscience will offset losses from the drop in Alligator Bioscience's long position.The idea behind KABE Group AB and Alligator Bioscience AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Alligator Bioscience vs. Cantargia AB | Alligator Bioscience vs. BioArctic AB | Alligator Bioscience vs. Oncopeptides AB | Alligator Bioscience vs. Hansa Biopharma AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |